The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 501–600 of 1,010
Wang, L., Lei, Y., Lu, Y., Chen, Y., Liu, T., Peng, Y., Zhou, Y., Cao, Y., Bi, Z., Liu, T., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445573 · Cited by 54
LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition
Hu, Q., Li, C., Wang, S., Li, Y., Wen, B., Zhang, Y., Liang, K., Yao, J., Ye, Y., Hsiao, H. H.-Y., et al. (2019) · Cell Research · doi:10.1038/s41422-018-0134-3 · Cited by 60
Pang, C., Lim, C. S., Brookes, J. A. S., Tsui, J. C. S., & Hamilton, G. (2020) · Vascular Medicine · doi:10.1177/1358863x20918941 · Cited by 56
miR-181 and Metabolic Regulation in the Immune System
Williams, A., Henao‐Mejia, J., Harman, C. C. D., & Flavell, R. A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020024 · Cited by 54
Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes
Xie, Y., Naizabekov, S., Chen, Z., & Tokay, T. (2016) · Oncology Letters · doi:10.3892/ol.2016.4636 · Cited by 54
Vadas, O., & Burke, J. E. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150065 · Cited by 52
Looy, T. V., Woźniak, A., Floris, G., Sciot, R., Li, H., Wellens, J., Vanleeuw, U., Fletcher, J. A., Manley, P. W., Dêbiec‐Rychter, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1823 · Cited by 56
Sánchez-Vega, F., Gotea, V., Margolin, G., & Elnitski, L. L. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0007-7 · Cited by 54
LI, D.-C., Zhang, Y., Xie, Y., Xiang, J., Zhu, Y., & Yang, J. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.14 · Cited by 55
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN
Sw, H., Moon, J.-H., Js, K., Shin, J.-S., KA, J. D. N., Wk, L., Jeong, S.-Y., Hwang, J. J., Lee, S., Suh, Y.-A., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.141 · Cited by 52
Estrella, J. S., Broaddus, R. R., Mathews, A., Milton, D. R., Yao, J. C., Wang, H., & Rashid, A. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0195-oa · Cited by 52
Xiang, S., Fang, J., WANG, S., Deng, B., & Zhu, L. (2014) · Oncology Reports · doi:10.3892/or.2014.3694 · Cited by 52
Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling
Hakim, S., Dyson, J. M., Feeney, S. J., Davies, E. M., Sriratana, A., Koenig, M. N., Plotnikova, O. V., Smyth, I., Ricardo, S. D., Hobbs, R. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw097 · Cited by 54
Auslander, N., Cunningham, C. E., Toosi, B. M., McEwen, E., Yizhak, K., Vizeacoumar, F. S., Parameswaran, S., Gonen, N., Freywald, T., Bhanumathy, K. K., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177739 · Cited by 55
Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.
Xia, X., Zhang, K., Luo, G., Cen, G., Cao, J., Huang, K., & Qiu, Z. (2017) · PubMed · Cited by 53
Phelps, M. A., Coss, C. C., Wang, H., Cook, M. S., & Reproducibility Project: Cancer Biology (2016) · eLife · doi:10.7554/elife.12470 · Cited by 51
Abbotts, R., Jewell, R., Nsengimana, J., Maloney, D. J., Simeonov, A. M., Seedhouse, C., Elliott, F., Laye, J. P., Walker, C., Jadhav, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1926 · Cited by 57
Molecular Pathways: Intercellular PTEN and the Potential of PTEN Restoration Therapy
Hopkins, B. D., & Parsons, R. E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2661 · Cited by 57
Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications
Chen, Z., & Lu, W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034560 · Cited by 56
The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy
Malaney, P., Uversky, V. N., & Davé, V. (2013) · Molecular BioSystems · doi:10.1039/c3mb70267g · Cited by 51
Eisenreich, W., Rudel, T., Heesemann, J., & Goebel, W. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00316 · Cited by 58
AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11
Piscitello, D., Varshney, D., Lilla, S., Vizioli, M. G., Reid, C., Gorbunova, V. A., Seluanov, A., Gillespie, D. A., & Adams, P. D. (2017) · Oncogene · doi:10.1038/onc.2017.340 · Cited by 53
Angelis, M. T. D., Parrotta, E. I., Santamaria, G., & Cuda, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0028-1 · Cited by 56
Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
Sundaram, M. K., Pramodh, S., Somvanshi, P., Bhardwaj, T., Mandal, R. K., Hussain, A., & Haque, S. (2019) · Genes · doi:10.3390/genes10120955 · Cited by 54
Du, C., Yi, X., Liu, W., Han, T., Liu, Z., Ding, Z., Zheng, Z., Piao, Y., Yuan, J., Han, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-869 · Cited by 52
Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
Frank, S. B., & Miranti, C. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00273 · Cited by 66
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia
Noguera, N. I., Song, M. S., Divona, M., Catalano, G., Calvo, K. L., García, F., Ottone, T., Florenzano, F., Faraoni, I., Battistini, L., et al. (2012) · Leukemia · doi:10.1038/leu.2012.314 · Cited by 50
Self-citationFalasca, M., & Fyffe, C. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35026 · Cited by 50
Redox Modulation of PTEN Phosphatase Activity by Hydrogen Peroxide and Bisperoxidovanadium Complexes
Lee, C., Hahne, G., Hanske, J., Bange, T., Bier, D., Rademacher, C., Hennig, S., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506338 · Cited by 55
The structural basis for cancer treatment decisions
Nussinov, R., Jang, H., & Tsai, C.-J. (2014) · Oncotarget · doi:10.18632/oncotarget.2439 · Cited by 49
Edimo, W. E., Ghosh, S., Derua, R., Janssens, V., Waelkens, E., Vanderwinden, J., Robe, P. A. J. T., & Erneux, C. (2016) · Journal of Cell Science · doi:10.1242/jcs.179663 · Cited by 51
Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids
Shahi Thakuri, P., Ham, S. L., Luker, G. D., & Tavana, H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00527 · Cited by 49
Modulation of VEGF receptor 2 signaling by protein phosphatases
Corti, F., & Simons, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.022 · Cited by 51
Loss of PTEN promotes formation of signaling-capable clathrin-coated pits
Rosselli‐Murai, L. K., Yates, J. A., Yoshida, S., Bourg, J. T., Ho, K. K. Y., White, M., Prisby, J., Tan, X., Altemus, M., Bao, L., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.208926 · Cited by 48
Lin, S., Wang, C., Ji, M., Wu, D., Lv, Y., Zhang, K., Dong, Y., Jin, J., Chen, J., Zhang, J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00416 · Cited by 51
Morphology regulation in vascular endothelial cells
Tsuji‐Tamura, K., & Ogawa, M. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0083-8 · Cited by 57
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart
Popov, S. V., Маслов, Л. Н., Naryzhnaya, N. V., Mukhomedzyanov, А. V., Krylatov, A. V., Tsibulnikov, S. Y., Ryabov, V. V., Cohen, M. V., & Downey, J. M. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211027405 · Cited by 51
Emerging role of tumor suppressor p53 in acute and chronic kidney diseases
Overstreet, J. M., Gifford, C. C., Tang, J., Higgins, P. J., & Samarakoon, R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04505-w · Cited by 58
Hawse, W. F., Sheehan, R. P., Miškov-Živanov, N., Menk, A. V., Kane, L., Faeder, J. R., & Morel, P. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402554 · Cited by 49
Mendelian disorders of PI metabolizing enzymes
Staiano, L., Leo, M. G. D., Persico, M., & Matteis, M. A. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.001 · Cited by 58
Xu, J., Li, Z., Wang, J., Chen, H., & Fang, J. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.02.004 · Cited by 53
Role of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling
Riehle, R. D., Cornea, S., & Degterev, A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_7 · Cited by 57
Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents
Chakravarti, B., Akhtar, T., Rai, B., Yadav, M. K., Siddiqui, J. A., Dwivedi, S. K. D., Thakur, R. K., Singh, A. K., Singh, A. K., Kumar, H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500873e · Cited by 52
Zhang, W., Lei, C., Fan, J., & Wang, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.034 · Cited by 52
Lee, S. H., Park, J., Byun, J.-K., Jhun, J., Jung, K., Seo, H.-B., Moon, Y., Kim, H., Park, S., & Cho, M. (2016) · Scientific Reports · doi:10.1038/srep34617 · Cited by 50
CanProVar 2.0: An Updated Database of Human Cancer Proteome Variation
Zhang, M., Wang, B., Xu, J., Wang, X., Xie, L., Zhang, B., Li, Y., & Li, J. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00505 · Cited by 51
Sahu, S., Dattani, A., & Aboobaker, A. A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.028 · Cited by 57
Regulation of the tumor suppressor PTEN by natural anticancer compounds
Kim, D., Suh, J., Surh, Y., & Na, H. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13422 · Cited by 52
Campo, J. A. D., García-Valdecasas, M., Gil‐Gómez, A., Rojas, Á., Gallego, P., Ampuero, J., Gallego‐Durán, R., Pastor, H., Grande, L., Ruiz, F. J. P., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191805 · Cited by 50
Aberrant expression of ETS1 and ETS2 proteins in cancer
Fry, E. A., & Inoue, K. (2018) · Cancer Reports and Reviews · doi:10.15761/crr.1000151 · Cited by 56
PTEN in kidney cancer: A review and meta-analysis
Que, W., Qiu, H., Cheng, Y., Liu, M., & Wu, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.031 · Cited by 49
The Tumor Microenvironment: Signal Transduction
Zhang, X., Ma, H., Gao, Y., Liang, Y., Du, Y., Hao, S., & Ni, T. (2024) · Biomolecules · doi:10.3390/biom14040438 · Cited by 64
Shenoy, S., Nanda, H., & Lösche, M. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.10.003 · Cited by 55
Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect
Xu, Y., Miriyala, S., Fang, F., Bakthavatchalu, V., Noel, T. J., Schell, D. M., Wang, C., Clair, W. H. S., & Clair, D. K. S. (2014) · Oncogene · doi:10.1038/onc.2014.355 · Cited by 49
Il-1β, Rage and Fabp4: Targeting the Dynamic Trio in Metabolic Inflammation and Related Pathologies
Hardaway, A., & Podgorski, I. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.90 · Cited by 52
Maugeri, G., D’Amico, A. G., Reitano, R., Magro, G. G., Cavallaro, S., Salomone, S., & D’Agata, V. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00139 · Cited by 53
Yang, M., Wang, H., Zhou, M., Liu, W., Kuang, P., Liang, H., & Yuan, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.12307 · Cited by 53
Improving oocyte quality by transfer of autologous mitochondria from fully grown oocytes
Kristensen, S. G., Pors, S. E., & Andersen, C. Y. (2017) · Human Reproduction · doi:10.1093/humrep/dex043 · Cited by 57
The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment
Qin, H., Liu, L., Sun, S., Zhang, D., Sheng, J., Li, B., & Yang, W. (2018) · PeerJ · doi:10.7717/peerj.5092 · Cited by 48
Macropinosomes as units of signal transduction
Swanson, J. A., & Yoshida, S. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0157 · Cited by 50
An update on PTEN modulators – a patent review
Boosani, C. S., Gunasekar, P., & Agrawal, D. K. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1669562 · Cited by 46
A new mathematical approach for qualitative modeling of the insulin-TOR-MAPK network
Nijhout, H. F., & Callier, V. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00245 · Cited by 49
MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes
Dou, L., Meng, X., Sui, X., Wang, S., Shen, T., Huang, X., Guo, J., Fang, W., Man, Y., Xi, J., et al. (2015) · Scientific Reports · doi:10.1038/srep11602 · Cited by 53
NOTCH and PTEN in prostate cancer
Bertrand, F. E., McCubrey, J. A., Angus, C. W., Nutter, J. M., & Sigounas, G. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.002 · Cited by 53
Rodríguez, J. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.005 · Cited by 51
Bhattacharya, K., Maiti, S., & Mandal, C. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.34 · Cited by 48
Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles
Cardoso, M. D. F. S., Castelletti, C. H. M., de Lima-Filho, J. L., Martins, D. B. G., & Teixeira, J. A. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.06.002 · Cited by 49
To, K. K. W., Wu, W. K. K., & Loong, H. H.-F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.036 · Cited by 49
Dong, S., Zhang, X., & Liu, D. (2019) · Biology Open · doi:10.1242/bio.041343 · Cited by 47
Lu, S., Strand, K. A., Mutryn, M. F., Tucker, R. M., Jolly, A., Furgeson, S. B., Moulton, K. S., Nemenoff, R. A., & Weiser‐Evans, M. C. M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313757 · Cited by 50
Flavonoid-Based Cancer Therapy: An Updated Review
Hosseinzadeh, E., Hassanzadeh, A., Marofi, F., Alivand, M. R., & Solali, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200423071759 · Cited by 55
Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis
Emami, S. S., Zhang, D., & Yang, X. (2020) · Cancers · doi:10.3390/cancers12092438 · Cited by 49
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Moestue, S. A., Dam, C. G., Gorad, S. S., Kristian, A., Bofin, A. M., Mælandsmo, G. M., Engebråten, O., Gribbestad, I. S., & Bjørkøy, G. (2013) · Breast Cancer Research · doi:10.1186/bcr3391 · Cited by 48
Blagden, S. P., Olmin, A., Josephs, D. H., Stavraka, C., Zivi, A., Pinato, D. J., Anthoney, A., Decordova, S., Swales, K. E., Riisnaes, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1315 · Cited by 46
Zhang, H., Zhao, B., Huang, C., Meng, X., Bian, E., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095520 · Cited by 46
Expression, activation, and role of AKT isoforms in the uterus
Fabi, F., & Asselin, É. (2014) · Reproduction · doi:10.1530/rep-14-0270 · Cited by 56
Gjorgjieva, M., Caldéraro, J., Monteillet, L., Silva, M., Raffin, M., Brevet, M., Romestaing, C., Roussel, D., Zucman‐Rossi, J., Mithieux, G., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.017 · Cited by 53
Sharma, S., Mathre, S., Visvanathan, R., Shinde, D. D., & Raghu, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.084 · Cited by 50
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
Piro, G., Carbone, C., Carbognin, L., Pilotto, S., Ciccarese, C., Iacovelli, R., Milella, M., Bria, E., & Tortora, G. (2019) · Cancers · doi:10.3390/cancers11101525 · Cited by 48
Lu, H., Chen, W., Liu, W., Si, Y., Zhao, T., Lai, X., Kang, Z., Sun, X., & Guo, Z. (2020) · The FASEB Journal · doi:10.1096/fj.201901981r · Cited by 47
Qi, Y., Liu, J., Chao, J. C., Scheuerman, M. P., Rahimi, S. A., Lee, L. Y., & Li, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69698-1 · Cited by 50
A systematic screening to identifyde novomutations causing sporadic early-onset Parkinson's disease
Kun‐Rodrigues, C., Ganos, C., Guerreiro, R. J., Schneider, S. A., Schulte, C., Lesage, S., Darwent, L., Holmans, P., Singleton, A., Bhatia, K. P., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv376 · Cited by 49
Current assessment of polo-like kinases as anti-tumor drug targets
Craig, S. N., Wyatt, M. D., & McInnes, C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.918100 · Cited by 45
Pten Regulates Development and Lactation in the Mammary Glands of Dairy Cows
Wang, Z., Hou, X., Qu, B., Wang, J., Gao, X., & Li, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102118 · Cited by 48
PTEN Phosphorylation and Nuclear Export Mediate Free Fatty Acid-Induced Oxidative Stress
Wu, Y., Zhou, H., Wu, K., Lee, S., Li, R., & Liu, X. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5498 · Cited by 48
Defining the Membrane-Associated State of the PTEN Tumor Suppressor Protein
Lumb, C. N., & Sansom, M. S. P. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.12.002 · Cited by 49
“Production of PI(3,4,5)P3 is normally regulated by the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor protein, which negatively regulates PI3-K signaling by converting PI(3,4,5)P3 back to PI(4,5) P2, thereby keeping the basal level of PI(3,4,5)P3 low (13,14) However, loss-of-function m…”
BackgroundPhosphatidylinositol‐3,4,5‐trisphosphate: Tool of choice for class I PI 3‐kinases
Salamon, R. S., & Backer, J. (2013) · BioEssays · doi:10.1002/bies.201200176 · Cited by 55
The PTEN protein: cellular localization and post-translational regulation
Leslie, N. R., Kriplani, N., Hermida, M. A., Garcia, V. A., & Wise, H. M. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150224 · Cited by 57
The Hidden Conundrum of Phosphoinositide Signaling in Cancer
Thapa, N., Tan, J. X., Choi, S., Lambert, P. F., Rapraeger, A. C., & Anderson, R. A. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.009 · Cited by 47
NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
Zhu, L., Li, L., Zhang, Q., Xiao, Y., Zou, Z., Hao, B., Marincola, F. M., Liu, Z., Zhong, Z., Wang, M., et al. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.11 · Cited by 48
Regulation of PTEN degradation and NEDD4–1 E3 ligase activity by Numb
Shao, C., Li, Z., Ahmad, N., & Liu, X. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1310351 · Cited by 47
Chamberlain, C. E., German, M. S., Yang, K. Y., Wang, J., VanBrocklin, H. F., Regan, M., Shokat, K. M., Ducker, G. S., Kim, G., Hann, B. C., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1204 · Cited by 45
Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study
Zota, A. R., Geller, R. J., VanNoy, B., Marfori, C. Q., Tabbara, S. O., Hu, L., Baccarelli, A., & Moawad, G. (2020) · Epigenetics Insights · doi:10.1177/2516865720904057 · Cited by 47
Combined PI3Kα-mTOR Targeting of Glioma Stem Cells
Eckerdt, F., Bell, J. B., Gonzalez, C., Oh, M. S., Perez, R. E., Mazewski, C., Fischietti, M., Goldman, S., Nakano, I., & Platanias, L. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-78788-z · Cited by 46
Zhang, Y.-Q., Liang, Y.-K., Wu, Y., Chen, M., Chen, W.-L., Li, R., Zeng, Y.-Z., Huang, W.-H., Wu, J.-D., Zeng, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03735-3 · Cited by 41
Signaling pathway intervention in premature ovarian failure
Bai, X., & Wang, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.999440 · Cited by 53
Jahromi, F. N. A., Dowran, R., & Jafari, R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01102-7 · Cited by 47
Liu, S., Parapuram, S. K., & Leask, A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38121 · Cited by 46
Huang, J., Chen, Z., REN, C.-M., Wang, D., YUAN, S.-X., Wu, Q., Chen, Q., Yu-hua, Z., Shao, Y., Li, Y., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4309 · Cited by 44
Huang, J. X., YUAN, S.-X., Wang, D., Wu, Q., Wang, X., Pi, C.-J., Zou, X., Chen, L., Ying, L.-J., Wu, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.016 · Cited by 44
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.